Valuation : Becton, Dickinson and Company

Market Cap 51.24B 44.12B 41.42B 37.81B 71.04B 4,875B 71.54B 491B 191B 2,472B 192B 188B 8,186B P/E 2026 *
36.2x
P/E 2027 * 20.2x
Enterprise Value 67.12B 57.79B 54.27B 49.54B 93.06B 6,387B 93.72B 643B 250B 3,239B 252B 247B 10,723B EV / Sales 2026 *
3.48x
EV / Sales 2027 * 3.3x
Free-Float
73.18%
Yield 2026 *
2.09%
Yield 2027 * 2.12%
1 day+0.43%
Current month-20.81%
Current year-20.81%
1 year 152.52
Extreme 152.52
192.59
3 years 152.52
Extreme 152.52
192.59
5 years 152.52
Extreme 152.52
253.98
10 years 152.52
Extreme 152.52
260
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
+0.43%+2.57% - - 51.24B
-1.88%-5.41%-16.81%+7.25% 191B
-0.64%-2.42%-2.33%+11.23% 116B
+0.49%-0.05%+10.97%+83.88% 61.75B
-0.74%-1.38%-2.52%-32.69% 51.24B
+1.18%-0.02%+29.20%+54.07% 51.51B
+0.26%-.--%+22.56%-9.82% 34.36B
-0.71%+0.95% - - 30.73B
+1.08%-3.46%+38.13%-16.17% 24.01B
+1.13%-1.96%-5.16%+15.32% 23.23B
Average +0.06%-1.41%+9.25%+14.13% 64.87B
Weighted average by Cap. -0.50%-1.93%+0.26%+15.56%

Financials

2026 *2027 *
Net sales 19.29B 16.61B 15.6B 14.24B 26.74B 1,836B 26.94B 185B 71.9B 931B 72.43B 70.86B 3,082B 19.73B 16.99B 15.95B 14.56B 27.36B 1,878B 27.55B 189B 73.55B 952B 74.09B 72.48B 3,152B
Net income 1.44B 1.24B 1.16B 1.06B 1.99B 137B 2.01B 13.76B 5.35B 69.32B 5.39B 5.28B 230B 2.34B 2.01B 1.89B 1.73B 3.24B 223B 3.27B 22.41B 8.72B 113B 8.78B 8.59B 374B
Net Debt 15.88B 13.68B 12.84B 11.72B 22.02B 1,511B 22.18B 152B 59.21B 766B 59.64B 58.35B 2,538B 13.95B 12.01B 11.28B 10.3B 19.34B 1,327B 19.48B 134B 52B 673B 52.38B 51.25B 2,229B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change
26/08/26 CHF 152.52 +0.43%
25/08/26 CHF 151.86 -0.65%
24/08/26 CHF 152.86 +0.24%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
188.11USD
Average target price
195.67USD
Spread / Average Target
+4.02%

Quarterly revenue - Rate of surprise